MAXEON SOLAR TECHNOLOGIE (MAXN)

SGXZ25336314 - Common Stock

9.98  -1.52 (-13.22%)

After market: 10.22 +0.24 (+2.4%)

Fundamental Rating

1

MAXN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. MAXN has a bad profitability rating. Also its financial health evaluation is rather negative. MAXN is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

MAXN had negative earnings in the past year.
In the past year MAXN has reported a negative cash flow from operations.
In the past 5 years MAXN always reported negative net income.
MAXN had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

The Return On Assets of MAXN (-47.51%) is worse than 88.89% of its industry peers.
Industry RankSector Rank
ROA -47.51%
ROE N/A
ROIC N/A
ROA(3y)-24.28%
ROA(5y)-21.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MAXN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

MAXN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MAXN has been reduced compared to 1 year ago.
MAXN has less shares outstanding than it did 5 years ago.
The debt/assets ratio for MAXN is higher compared to a year ago.

2.2 Solvency

MAXN has an Altman-Z score of -1.29. This is a bad value and indicates that MAXN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.29, MAXN is doing worse than 76.85% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.29
ROIC/WACCN/A
WACC8.36%

2.3 Liquidity

MAXN has a Current Ratio of 1.36. This is a normal value and indicates that MAXN is financially healthy and should not expect problems in meeting its short term obligations.
MAXN has a Current ratio of 1.36. This is amonst the worse of the industry: MAXN underperforms 81.48% of its industry peers.
MAXN has a Quick Ratio of 1.36. This is a bad value and indicates that MAXN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MAXN (0.55) is worse than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.55

2

3. Growth

3.1 Past

The earnings per share for MAXN have decreased strongly by -20491.44% in the last year.
Looking at the last year, MAXN shows a very negative growth in Revenue. The Revenue has decreased by -34.57% in the last year.
MAXN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.25% yearly.
EPS 1Y (TTM)-20491.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4166.67%
Revenue 1Y (TTM)-34.57%
Revenue growth 3Y9.96%
Revenue growth 5Y4.25%
Sales Q2Q%-47.12%

3.2 Future

Based on estimates for the next years, MAXN will show a very strong growth in Earnings Per Share. The EPS will grow by 25.99% on average per year.
The Revenue is expected to decrease by -2.18% on average over the next years.
EPS Next Y96.81%
EPS Next 2Y40.86%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year-46.56%
Revenue Next 2Y-16.84%
Revenue Next 3Y-2.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

MAXN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MAXN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as MAXN's earnings are expected to grow with 25.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.86%
EPS Next 3Y25.99%

0

5. Dividend

5.1 Amount

No dividends for MAXN!.
Industry RankSector Rank
Dividend Yield N/A

MAXEON SOLAR TECHNOLOGIE

NASDAQ:MAXN (11/15/2024, 8:24:35 PM)

After market: 10.22 +0.24 (+2.4%)

9.98

-1.52 (-13.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap140.62M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.51%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.36
Quick Ratio 0.55
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-20491.44%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y96.81%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-34.57%
Revenue growth 3Y9.96%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y